A large-scale database of T-cell receptor beta (TCRβ) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.
2020 · Research Square · 164 citations
https://doi.org/10.21203/rs.3.rs-51964/v1
C
Claudio Cerchione
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori(IT)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
271
Papers
3.1K
Citations
29
h-index
76
i10-index
Claudio Cerchione is an academic researcher from Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Protein Degradation and Inhibitors & Acute Myeloid Leukemia Research. The author has an h-index of 29, co-authored 231 publications.
ORCID: 0000-0002-9104-5436Papers by this author
worksChronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients?
2021 · Translational Oncology · 35 citations
https://doi.org/10.1016/j.tranon.2021.101300
Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience
2016 · Supportive Care in Cancer · 24 citations
https://doi.org/10.1007/s00520-016-3468-8
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy
2025 · Frontiers in Immunology · 13 citations
https://doi.org/10.3389/fimmu.2025.1515748
Patients with multiple myeloma referred for palliative care consultation: from retrospective analysis to future directions to improve clinical outcomes
2021 · Supportive Care in Cancer · 11 citations
https://doi.org/10.1007/s00520-021-06560-8
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma
2024 · Nature Communications · 9 citations
https://doi.org/10.1038/s41467-024-45350-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat